<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" id="inlinetable2" position="anchor"><table frame="hsides" rules="groups"><tbody><tr><td valign="top">Experiments: <break/>referenced figures</td><td valign="top">Novel or Replicate experiment (article reference if replication)</td><td valign="top">Comments</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig1">Figure 1A</xref></td><td valign="top">Novel</td><td valign="top">Expression of Necdin in 5-HT neuronal precursors has never been shown</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig1">Figure 1B</xref></td><td valign="top">Novel</td><td valign="top">Such disorganization when the 5-HT nuclei should be set up was not reported in any previous publication.</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig1">Figure 1C</xref></td><td valign="top">Replicate (Zanella et al., 2008; Rieusset et al; 2013)</td><td valign="top">The number of 5-HT neurons has been counted in the <italic>Ndn -/-</italic> mice studied in this article. Previously (Zanella, 2008) we showed that in <italic>Ndn+m/-p</italic> mice, the number of 5-HT neurons was not significantly reduced compared with WT. However we showed that Ndn +/-p mice present a high variability in the severity of the phenotype, cellular defects due to a stochastic and faint expression of the maternal allele in some mice. To avoid this variability we chose to study <italic>Ndn-</italic>/- mice.</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig1">Figure 1D</xref></td><td valign="top">Novel</td><td rowspan="5" valign="top">It&#8217;s the first time that defects in radial migration of <italic>Ndn</italic>-deficient 5-HT precursors are shown <italic>in vivo</italic> using twophoton time-lapse imaging. Furthermore, our study revealed a problem of somal translocation. Problems of migration of other neuronal populations in <italic>Ndn-</italic>KO mice have been suggested but never shown <italic>in vivo</italic>.</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig1">Figure 1E</xref></td><td valign="top">Novel</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig1">Figure 1F</xref></td><td valign="top">Novel</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig1">Figure 1G</xref></td><td valign="top">Novel</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig1">Figure 1H</xref></td><td valign="top">Novel</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig1">Figure 1I</xref></td><td valign="top">Novel</td><td rowspan="3" valign="top">Electrophysiological recordings of 5-HT neurons in <italic>Ndn-KO</italic> mice have never been reported.</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig1">Figure 1J</xref></td><td valign="top">Novel</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig1">Figure 1K</xref></td><td valign="top">Novel</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig1s1">Figure 1&#8212;figure supplement 1 A-I</xref></td><td valign="top">Novel</td><td valign="top">This panel shows (for the first time) the expression of Necdin in Pet-EYFP 5-HT precursors at E10.5. Then we show that Necdin is expressed in all 5-HT neurons in raphe nuclei. Again, the expression of Ndn by immunohistochemistry in all 5-HT raphe nuclei has never been shown (only suggested in Zanella).</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig1">Figure 1J</xref></td><td valign="top">Replicate (Lee et al., 2005)</td><td valign="top">Indeed, we looked at the distribution of 5-HT neurons in <italic>Ndn</italic>-KO mice at nearly all development stages; we chose to show the E12.5 and E16.5 because they suggest a delay in migration. Previously, Lee et al. showed a similar defect at E12.5, in their <italic>Ndn</italic>- KO model, proposing a defect in serotonergic projections reflecting a more general delay or dysfunction of axonal projections. We think that it is important to show that this defect is present in both <italic>Ndn</italic>-KO mouse models.</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig2">Figure 2A-2B</xref></td><td valign="top">Novel</td><td valign="top">The abnormal 5-HT fibers with &#8220;large varicosities &#8220;were previously described (Pagliardini et al., 2005; Zanella et al., 2008). The novelty here is: the quantification in different brain structures of the 5-HT LPAs and, importantly the fact that we show that those 5-HT LPAs disappear in <italic>Ndn/Slc6a4</italic>-DKO (normal labelling being present in <italic>Slc6a4</italic>-KO mice).</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig2">Figure 2C-2D</xref></td><td valign="top">All Novels</td><td valign="top">The quantification of SERT in <italic>Ndn</italic>-KO has never been done until this study.</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig2">Figure 2E-2H</xref></td><td valign="top">All Novels</td><td valign="top">ASP+uptake assays in <italic>Ndn</italic>-KO serotonergic cells (primary cultures of raphe) compared with WT and SERT-KO (negative control) cells have never been done previously. This experiment allows to assess the activity of SERT as a transporter leading to an uptake of ASP+.</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig2s1">Figure 2&#8212;figure supplement 1A</xref></td><td valign="top">Novel</td><td valign="top">L-Trp quantification (5-HT substrate) has never been done in Ndn-KO mice.</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig2s1">Figure 2&#8212;figure supplement 1D</xref></td><td valign="top">Replicate (Zanella et al., 2008)</td><td valign="top">5-HT and 5-HIAA were previously quantified in <italic>Ndn</italic>+m/-p. It was necessary to quantify them here in the <italic>Ndn</italic>-/- animals and to include those quantifiactions in a more complete analysis of the 5-HT system.</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig2s1">Figure 2&#8212;figure supplement 1E</xref></td><td valign="top">Novel</td><td valign="top"><italic>Tph2</italic> transcripts have not been quantified previously.</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig2s1">Figure 2&#8212;figure supplement 1F</xref></td><td valign="top">All Novels</td><td valign="top"><italic>Slc6a4</italic> (Sert) tanscripts have not been quantified previously.</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig2s2">Figure 2&#8212;figure supplement 2A - 2B</xref></td><td valign="top">All Novels</td><td valign="top">Illustration of the ASP+ uptake in the 5- HT neurons.</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig3">Figure 3A-3H</xref></td><td valign="top">All novels</td><td valign="top">Plethysmography recordings and breathing parameters analysis of <italic>in vivo</italic> Fluoxetine treatment in early life of Necdin deficient mice or Ndn/Sl6a4 DKO mice in comparison with Ndn-KO or WT mice. Recordings are performed at P15 (O DAT) after a 10 days treatment with Fluoxetine.</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig3s1">Figure 3&#8212;figure supplement 1A to H</xref></td><td valign="top">All novels</td><td valign="top">Similar experiments as performed in <xref ref-type="fig" rid="fig3">Figure 3</xref> but performed at 15 DAT and 30 DAT in order to assess a mid/long term effect of fluoxetine treatment.</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig3s2">Figure 3&#8212;figure supplement 2A to E</xref></td><td valign="top">All novels</td><td valign="top"/></tr><tr><td valign="top"><xref ref-type="fig" rid="fig4">Figure 4 A to L</xref></td><td valign="top">All novels</td><td valign="top"><italic>In vivo</italic> <bold>hypercapnia</bold> and <italic>in vitro</italic> acidosis have never been assessed either in <italic>Ndn</italic>KO mice or in <italic>Ndn-</italic>KO brainstem-spinal cord preparations treated or not with fluoxetine. In our previous study (Zanella et al., 2008) <bold>hypoxia</bold> only was assessed.</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig4s1">Figure 4&#8212;figure supplement 1</xref></td><td valign="top">All novels</td><td valign="top">8-OH-DPAT on <italic>Ndn</italic>-KO brainstem-spinal cord <italic>in vitro</italic> preparations has never been assessed previously.</td></tr><tr><td valign="top"><xref ref-type="fig" rid="fig4s2">Figure 4&#8212;figure supplement 2</xref></td><td valign="top">Novel experiment: treatment with 8-OHDPAT Replicate experiment: acidosis in WT preparations treated or not with fluoxetine (Voituron et al., 2010)</td><td valign="top">In 2010, Voituron et al. showed that &#8220;Fluoxetine Treatment Abolishes the In Vitro Respiratory Response to Acidosis in Neonatal Mice&#8221;. In our study, since we investigated the effect of fluoxetine in <italic>Ndn</italic>-KO brainstem-spinal cord preparations submitted to acidosis, the experiments in control animals were mandatory and are presented in this figure. Here, we added a novel experiment in control mice: the effect of 8-OH-DAPT.</td></tr></tbody></table></table-wrap>